Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1390 of 6351
-
Probiotic spores in sugar may tame hidden inflammation in overweight adults
Disease control By invitation onlyThis randomized, double-blind, controlled, crossover study investigates the effects of a sugar-based synbiotic product containing inulin and Bacillus coagulans BC30™ spores in healthy overweight individuals. Twenty participants complete a 2-week run-in period and two 4-week inter…
Sponsor: Federico II University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Heart failure patients may benefit from simple nutrient supplements
Disease control Recruiting nowThe goal of this clinical trial is to learn whether taking selenium and coenzyme Q10 (CoQ10) can reduce HF related events and deaths related to cardiovascular disease. Researchers will compare selenium-CoQ10 supplements with a placebo to see if the supplements improve heart heal…
Phase 3 • Sponsor: Netherlands Heart Institute • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New breathing tube removal method may protect fragile preterm lungs
Disease control Recruiting nowMany babies born very preterm (\<32 weeks of pregnancy) require support to breathe from a breathing machine (mechanical ventilator) via a breathing tube. Although this keeps babies alive, it can damage their lungs. To reduce this damage, doctors and nurses try to change babies to…
Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Chair yoga: a Drug-Free key to better sleep and less pain in old age?
Symptom relief CompletedThis study was designed to evaluate the effect of chair-supported yoga on sleep quality and pain levels in individuals aged 65 and over living in nursing homes. Today, with the increase in the elderly population, sleep disorders and musculoskeletal pain negatively affect the qual…
Sponsor: Rüveyda Berk • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Can a tiny Add-On make knee surgery numbing last longer?
Symptom relief By invitation onlyThis study aims to determine whether lower doses (4 µg) of intrathecal dexmedetomidine can provide comparable analgesic benefits while minimizing adverse hemodynamic effects in patients encountered in our setup( Shifa International Hospital Islamabad). Studies conducted earlier i…
Phase 1/2 • Sponsor: Shifa International Hospital • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Glow-in-the-dark dye could help surgeons spot hidden cancer during head and neck surgery
Diagnosis Recruiting nowThis study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyanine Green (ICG) dye allows for better identification of tumor tissue during surgical procedures. Participation will includ…
Phase 2 • Sponsor: Medical University of South Carolina • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New 20-Minute test could spot deadly virus at bedside
Diagnosis Recruiting nowThe goal of this medical device diagnostic evaluation study is to determine if this novel lateral flow device can detect Crimean-Congo Hemorrhagic Fever (CCHF) at the point of care in secondary health care clinics in Turkey. The main outcome is to determine the sensitivity and sp…
Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
New blood test aims to predict sepsis in minutes, not hours
Diagnosis Recruiting nowThe primary objective of this study is to establish an IL-6 concentration cutoff that predicts sepsis or septic shock (according to the Third International Consensus Definitions (Sepsis-3 criteria)) in patients who are admitted or are intended to be admitted to the hospital from …
Sponsor: Bluejay Diagnostics, Inc. • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New drug combo aims to shrink spleen in Hard-to-Treat myelofibrosis
Disease control Not yet recruitingThis is a phase II, multicenter, open-label trial evaluating the safety and efficacy of pacritinib and selinexor in JAK inhibitor naïve patients with anemia and thrombocytopenia.
Phase 2 • Sponsor: John Mascarenhas • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug combo aims to tame Crohn's Flare-Ups
Disease control Recruiting nowThe main purpose of this study is to see how the safety and efficacy of a farnesoid X receptor (FXR) agonist (LY4395089), given together with mirikizumab compares with mirikizumab (alone) in adults with moderately to severely active Crohn's disease (CD). This study is part of the…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for gut disease: experimental drugs enter human trials
Disease control Recruiting nowStudy IIBD is a master protocol that will support a collection of individual sub studies that share key design components. Participants will be assigned to the appropriate study prior to randomization to a treatment group. The studies aim to evaluate the efficacy and safety of ne…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New mRNA vaccine targets Epstein-Barr virus in first human trial
Vaccine Not yet recruitingThis is an adaptive design Phase 1 clinical trial to evaluate the safety and immunogenicity of VXCO-102 in healthy adult participants.
Phase 1 • Sponsor: Vaccine Company, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 12:25 UTC
-
New procedure targets nerves to ease stubborn back pain
Symptom relief Recruiting nowDetermination of efficacy and safety of Monopolar Basivertebral Nerve Ablation for Axial Low Back Pain treatment, including the method optimization.
Sponsor: EPC Education s.r.o. • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Could oral antibiotics replace hospital stays for Syphilis-Exposed newborns?
Disease control Recruiting nowCARES-1 is a randomised, open-label, phase II pharmacokinetic (PK) and safety study of ambulatory antibiotics for the treatment of neonates with "all-risk" asymptomatic congenital syphilis.
Phase 2 • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New writing therapy aims to ease fear in advanced cancer patients
Symptom relief Recruiting nowPrecision oncology has led to a growing population of adults with advanced cancer living increasingly longer lives in the face of profound uncertainty about the future, with over half reporting moderate to high fear of cancer progression (FoP). These fears are associated with anx…
Sponsor: University of Colorado, Boulder • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Can a gentler gum treatment change the chemical signature of periodontitis?
Disease control Recruiting nowA double-blind randomized-controlled clinical trial is conducted in order to evaluate the impact of non-surgical periodontal treatment by means of minimally invasive approach MINST or Q-SI (quadrantwise) approach in subjects with periodontitis on targeted metabolomics in gingival…
Sponsor: University of Catania • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Home exercises may steady the steps of seniors with dizziness
Symptom relief OngoingThe goal of this feasibility pilot randomised controlled trial is to determine whether a home-based exercise programme integrated with a self-managed education programme is feasible, acceptable, and safe for adults aged 60 years and older with benign paroxysmal positional vertigo…
Sponsor: Muhammad Hizami bin Mustafa • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
VR meets ketamine: a new hope for stubborn depression?
Symptom relief Recruiting nowDepression is a common condition, with serious negative effects on the health and quality of life of those affected. While there are currently various medications which attempt to treat depression, they often take a long time to begin to work and do not work at all for many peopl…
Phase 3 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Could an old drug save your sight? disulfiram trial targets vision loss
Disease control Recruiting nowAberrant retinoic acid signaling driven by the degenerating outer retina leads to pathological changes to the inner retina. The resulting hyperactivity of retinal ganglion cells leads to further diminution of the remaining vision in those afflicted with inherited retinal diseases…
Phase 1/2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New app could help kids with diabetes dose insulin safely
Disease control Recruiting nowThis is a multi-centre, prospective, randomized, open-label controlled trial designed to evaluate the effectiveness of a flexible digital insulin dose calculator in children under 12 years of age with Type 1 Diabetes Mellitus (T1DM) managed with multiple daily injections (MDI). P…
Sponsor: Sultan Qaboos University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC